Investigational immunotherapy treatment shows durable response in patients with metastatic melanoma

26 mayo 2015

Advanced-stage melanoma patients have significant improvement in durable response rate when treated with a genetically-modified form of a herpes virus, whose native form causes the common cold sore, new research shows.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/7OSte_M-S4Y/150526171902.htm

Volver